Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Receivables (2023 - 2025)

Historic Change in Receivables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$254000.0.

  • Upstream Bio's Change in Receivables fell 36185.57% to -$254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $76000.0, marking a year-over-year decrease of 7777.78%. This contributed to the annual value of $515000.0 for FY2024, which is 26401.27% up from last year.
  • Upstream Bio's Change in Receivables amounted to -$254000.0 in Q3 2025, which was down 36185.57% from $371000.0 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Change in Receivables registered a high of $640000.0 during Q1 2024, and its lowest value of -$254000.0 during Q3 2025.
  • In the last 3 years, Upstream Bio's Change in Receivables had a median value of -$20500.0 in 2024 and averaged $52250.0.
  • The largest annual percentage gain for Upstream Bio's Change in Receivables in the last 5 years was 26271.93% (2025), contrasted with its biggest fall of 36185.57% (2025).
  • Upstream Bio's Change in Receivables (Quarter) stood at -$167000.0 in 2023, then surged by 103.59% to $6000.0 in 2024, then tumbled by 4333.33% to -$254000.0 in 2025.
  • Its Change in Receivables was -$254000.0 in Q3 2025, compared to $371000.0 in Q2 2025 and -$47000.0 in Q1 2025.